Patents by Inventor Elizabeth K. Kauffman

Elizabeth K. Kauffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030064077
    Abstract: Attenuated recombinant viruses containing DNA encoding an HCMV antigen, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses. The DNA of the recombinant viruses can be used as probes or for generating PCR primers.
    Type: Application
    Filed: July 26, 2001
    Publication date: April 3, 2003
    Applicant: Virogenetics Corporation
    Inventors: Enzo Paoletti, Steven E. Pincus, William I. Cox, Elizabeth K. Kauffman
  • Patent number: 6267965
    Abstract: Attenuated recombinant viruses containing DNA encoding an HCMV antigen, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses. The DNA of the recombinant viruses can be used as probes or for generating PCR primers.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: July 31, 2001
    Assignee: Virogenetics Corporation
    Inventors: Enzo Paoletti, Steven E. Pincus, William I. Cox, Elizabeth K. Kauffman